Table 1—

Pertinent clinical characteristics and glucometabolic data of patients with NGT, IGT, and diabetes as seen during the hospital phase and follow-up

VariableNGTIGTDiabetesP value
n505936
Age (years)61.4 ± 9.363.9 ± 9.364.7 ± 9.10.214
BMI (kg/m2)26 ± 4.526 ± 3.928 ± 3.40.199
Male (%)7470720.871
Current smokers (%)3834330.802
Family history of type 2 diabetes (%)1824200.746
Previous disorders (%)
 Myocardial infarction1020280.102
 Angina pectoris2641310.250
 Hypertension (treated)2646190.014
 Hyperlipidemia (treated)1219140.610
Treatment during hospital stay and at discharge (%)
 Thrombolysis3643420.740
 Aspirin9295940.816
 β Blockers8697940.104
 ACE inhibitors3641440.716
 Statins6267690.746
Metabolic parameters
 Blood glucose (mmol/l)
  At admission6.0 (1.4)6.2 (1.6)7.1 (2.2)0.047
  At discharge5.0 (0.65)5.1 (0.93)5.6 (0.83)0.001
 HbA1c day 2(%)4.7 (0.55)4.9 (0.65)5.2 (0.90)0.001
 Insulin (pmol/l)
  Day 260.5 (57.5)55.0 (60.0)70.0 (67.3)0.052
  Day 552.0 (51.0)52.0 (47.0)71.6 (47.3)0.087
  3 months47.0 (42.3)50.5 (39.3)70.5 (54.0)0.027
 2-h insulin (pmol/l)
  Day 5341 (368)390 (424)534 (574)0.026
  3 months178 (190)360 (323)560 (543)0.000
 Proinsulin (pmol/l)
  Day 55.4 (3.5)5.8 (3.9)7.8 (6.4)0.015
  3 months5.5 (4.5)5.2 (4.6)8.4 (6.5)0.002
 Lipids
  Triglycerides day 2 (mmol/l)1.8 (1.3)2.0 (1.6)2.5 (1.4)0.027
  Total cholesterol (mmol/l)6.1 (1.5)5.4 (1.2)6.1 (2.2)0.735
  HDL cholesterol day 2 (mmol/l)1.2 (0.4)1.2 (0.4)1.1 (0.3)0.05
  • Data are mean ± SD or median (interquartile range). P values based on Jonckheere-Terpstra test for trend or χ2 test.